Apr 12 |
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
|
Apr 10 |
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
|
Apr 10 |
Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?
|
Apr 9 |
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Apr 9 |
Syros jumps on FDA fast track tag for leukemia drug
|
Apr 9 |
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
|
Apr 2 |
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 2 |
Top 3 Health Care Stocks You'll Regret Missing This Month
|
Mar 28 |
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Syros Pharmaceuticals Full Year 2023 Earnings: Misses Expectations
|